WESLEY C VAN VOORHIS
Osteopathic Medicine at Pacific St, Seattle, WA
License number
Washington MD00023958
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
1959 NE Pacific St, Seattle, WA 98195
Phone
(206) 598-7600
(206) 543-6420
(206) 543-6420
Personal information
See more information about WESLEY C VAN VOORHIS at radaris.comName
Address
Phone
Seattle, WA
Professional information
Senior Designer
Location:
Greater Seattle Area
Industry:
Architecture & Planning
Sr. Cad System Analyst At Weyerhaeuser
Location:
Greater Seattle Area
Industry:
Renewables & Environment
Compositions And Methods For Treating Toxoplasmosis, Cryptosporidiosis, And Other Apicomplexan Protozoan Related Diseases
US Patent:
2013001, Jan 17, 2013
Filed:
Jul 30, 2012
Appl. No.:
13/561896
Inventors:
Wesley C. VAN VOORHIS - Seattle WA, US
Wilhelmus G.J. HOL - Kenmore WA, US
Eric T. LARSON - Bethel CT, US
Dustin James MALY - Seattle WA, US
Ethan MERRITT - Seattle WA, US
Kayode K. OJO - Federal Way WA, US
Wilhelmus G.J. HOL - Kenmore WA, US
Eric T. LARSON - Bethel CT, US
Dustin James MALY - Seattle WA, US
Ethan MERRITT - Seattle WA, US
Kayode K. OJO - Federal Way WA, US
Assignee:
University of Washington through its Center for Commercialization - Seattle WA
International Classification:
A61K 31/519, A61K 31/4985, A61K 31/517, A61K 31/433, A61K 31/4045, A61K 31/404, A61K 31/52, A61K 31/44, A61K 31/553, A61K 31/5377, A61P 33/02, A61P 33/06, C07D 487/04, A61K 31/55
US Classification:
51421108, 544350, 514249, 544262, 5142621, 5142664, 514361, 514414, 51421207, 5142634, 514350, 5142345, 514418
Abstract:
Compositions and methods for the treatment of toxoplasmosis, caused by the infectious eukaryotic parasite () and for the treatment of cryptosporidiosis, caused by the infectious eukaryotic parasites () and () are described. In particular, the present disclosure is directed to compositions and methods for inhibiting either calcium dependent protein kinases (TgCDPKs) or and calcium dependent protein kinases (CpCDPKs) using pyrazolopyrimidine and/or imidazo[1,5-a]pyrazine inhibitors, of the formula,wherein the variables X, Y, Z, L, R, and Rare defined herein.
Compositions And Methods For Predicting Inhibitors Of Protein Targets
US Patent:
2012014, Jun 7, 2012
Filed:
Jul 6, 2007
Appl. No.:
12/309143
Inventors:
Michael Lagunoff - Seattle WA, US
Wesley C. Van Voorhis - Seattle WA, US
Ekachai Jenwitheesuk - Ratchaburi, TH
Ram Samudrala - Mukilteo WA, US
Wesley C. Van Voorhis - Seattle WA, US
Ekachai Jenwitheesuk - Ratchaburi, TH
Ram Samudrala - Mukilteo WA, US
International Classification:
A61K 31/4439, A61K 31/497, A61K 31/404, A61K 31/426, A61K 31/415, G06G 7/60, A61K 31/603, A61P 31/22, A61P 31/18, A61P 33/02, C40B 30/02, A61K 31/704, A61K 31/702
US Classification:
514 34, 514333, 51425214, 514414, 514370, 514407, 514 61, 514160, 506 8, 703 11
Abstract:
Compositions and methods are provided for predicting inhibitors of protein targets related to treatment of infectious disease, for example, bacterial, viral, or parasitic diseases. Methods are provided for predicting inhibitors of protein targets related to treatment infectious disease, for example, microbial disease, utilizing a docking with dynamics protocol to identify inhibitors, or utilizing a protein structure energy function to identify peptide or peptidomimetic inhibitors.
Syphilis Diagnostic Tests And Kits
US Patent:
2010000, Jan 7, 2010
Filed:
Jun 25, 2009
Appl. No.:
12/491715
Inventors:
Wesley C. Van Voorhis - Seattle WA, US
Caroline E. Cameron - Victoria, CA
Sheila A. Lukehart - Seattle WA, US
Caroline E. Cameron - Victoria, CA
Sheila A. Lukehart - Seattle WA, US
Assignee:
WASHINGTON, UNIVERSITY OF - Seattle WA
University of Victoria Innovation and Development Corporation - Victoria
University of Victoria Innovation and Development Corporation - Victoria
International Classification:
G01N 33/571, C07K 14/195, C12N 15/74, C12N 1/21
US Classification:
435 736, 530350, 4353201, 4352523
Abstract:
The present invention provides methods and kits for determining whether a human subject is infected with and isolated polypeptide fragments of proteins Tp92, Tp0453, and Gpd that can be used in the methods and kits of the invention.